NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 50 of 176 results found.

Activity Company Description Location
Company Propella Therapeutics Inc. Activity: Research and Development Research and Development Company Description Propella Therapeutics has developed a platform which combines lymphatic targeting with a medicinal chemistry optimization process to create therapeutics for cancer. The lead asset is PRL-02 (abiraterone decanoate) for prostate cancer. Location Pittsboro
Company Acclivity Technologies Inc. Activity: Research and Development Research and Development Company Description Acclivity is a virtual pharma company developing novel small molecule therapeutics for treatment of peripheral artery disease and other cardiovascular, inflammatory and ischemic disease indications, vasculitis and type 2 diabetes. Location Raleigh
Company AccuNovo Biotechnologies Inc. Activity: Research and Development Research and Development Company Description Accunovo is developing novel targeted PET imaging probes through a combination of unique biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors. Location Chapel Hill
Company Achelios Therapeutics Inc. Activity: Research and Development Research and Development Company Description Achelios Therapeutics develops novel topical therapies for inflammatory pain, such as joint, muscle temporomandibular and migraine pain. Location Durham
Company Adroit Pharmaceutical Development LLC Activity: Contract Research and Testing Contract Research and Testing Company Description Adroit Pharmaceutical Development identifies new and improved formulations and process technologies. Its primary focus is on inhalation and dermatological product development. Location Durham
Company AegisCN LLC Activity: Research and Development Research and Development Company Description AegisCN develops technologies and treatments targeting neurological diseases and inflammation. Location Durham
Company Aer Therapeutics Activity: Research and Development Research and Development Company Description Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung diseases with excess mucus and mucus plugs. Location Raleigh
Company Aerami Therapeutics Activity: Research and Development Research and Development Company Description Aerami is developing therapies to address the unmet medical needs of people with serious and rare forms of pulmonary hypertension, including pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. Location Durham
Company Aestas Pharma Inc. Activity: Research and Development Research and Development Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the detection, early treatment and reversal of Alzheimer’s disease when clinical signs are not yet pronounced. Location Durham
Company AimMax Therapeutics Inc. Activity: Research and Development Research and Development Company Description AimMax Therapeutics researches and develops biopharmaceuticals for the treatment of infection, inflammation and pain through in-licensing or co-development with strategic partners. Location Durham
Company Aktis Oncology Activity: Research and Development Research and Development Company Description Aktis Oncology is developing targeted radiopharmaceuticals to treat solid tumor cancers. Location Durham
Company AlphaVax Inc. Activity: Research and Development Research and Development Company Description AlphaVax develops vaccine technology with applications in infectious disease, cancer and biodefense threats. Location Research Triangle Park
Company AMO Pharma Ltd. Activity: Research and Development Research and Development Company Description AMO Pharma is developing new treatments for serious and debilitating diseases including rare genetic disorders. Location Durham
Company Aniluxx Biotechnology Inc. Activity: Research and Development Research and Development Company Description Aniluxx Biotechnology translates human therapies to dogs, cats and horses to treat itching and pain. Location Chapel Hill
Company APIE Therapeutics Inc. Activity: Research and Development Research and Development Company Description APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies. Location Research Triangle Park
Company Archerfish Co. Activity: Research and Development Research and Development Company Description Archerfish develops small molecule drugs to reduce tissue fibrosis and corneal scarring. Location Cary
Company Ardeal Pharma Inc. Activity: Research and Development Research and Development Company Description Ardeal Pharma is a virtual pharma company developing patented stabilized sulforaphane for the dermal pharmaceutical and cosmetic markets. Location Brevard
Company Ardeal Research Institute Activity: Research and Development Research and Development Company Description Ardeal Research Institute is a non-profit organization that develops drug discovery capabilities of the natural resources in Western North Carolina. The Institute has collaboration agreements in place with Brevard College and the N.C. Arboretum. Location Brevard
Company Areteia Therapeutics Inc. Activity: Research and Development Research and Development Company Description Areteia Therapeutics is developing the first oral drug for eosinophilic asthma. Location Chapel Hill
Company Arrivo BioVentures LLC Activity: Research and Development Research and Development Company Description Arrivo BioVentures accelerates biologics and small molecules from IND readiness through a clinical proof of concept, with biologics in development for dermatologic conditions. Location Morrisville
Company Atsena Therapeutics Inc. Activity: Research and Development Research and Development Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. Location Durham
Company Auration Biotech Inc. Activity: Research and Development Research and Development Company Description Auration Biotech is developing novel therapeutics for ear, nose and throat diseases. Location Chapel Hill
Company Avior Inc. Activity: Research and Development Research and Development Company Description Avior is a clinical-stage pharmaceutical company developing treatments for patients suffering from chronic liver disease (CLD) associated pruritus and pruritus in atopic dermatitis. Location Cary
Company Ballek Biologics LLC Activity: Research and Development Research and Development Company Description Ballek Biologics is developing a therapeutic to reverse opioid overdose. Location Raleigh
Company Bantam Pharmaceutical LLC Activity: Research and Development Research and Development Company Description Bantam Pharmaceutical develops small molecule cancer therapeutics for hematological malignancies and select solid tumors. Location Durham
Company Base4 Biotechnology Inc. Activity: Research and Development Research and Development Company Description Base4 is developing a biotechnology platform designed to visualize RNA dynamics at the atomic level. The company's platform aids in small molecule drug discovery. Location Durham
Company Basking Biosciences Inc. Activity: Research and Development Research and Development Company Description Basking Biosciences is developing a reversible anti-thrombotic therapeutic to treat ischemic stroke. Location Research Triangle Park
Company BE Pharmaceuticals USA Inc. Activity: Sales and Operations Sales and Operations Company Description BE Pharmaceuticals USA is the US office for Biological E Ltd., a vaccine manufacturing company headquartered in India. Location Cary
Company Bedrock Therapeutics Inc. Activity: Research and Development Research and Development Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. Location Raleigh
Company Belhaven Biopharma Inc. Activity: Research and Development Research and Development Company Description Belhaven Biopharma is developing dry powder nasal products for a variety of indications. Location Raleigh
Company BioAesthetics Corporation Activity: Research and Development Research and Development Company Description BioAesthetics Corporation is developing biomaterials, including the NACgraft, a nipple areolar complex graft to be used in regenerating the nipple-areolar complex for mastectomy patients. Location Durham
Company BioKier Inc. Activity: Research and Development Research and Development Company Description BioKier develops proprietary adjuvant treatments for diabetes and related disorders. BioKier has identified a therapeutic opportunity based on gastric bypass surgery and is developing several novel treatments for cardiometabolic diseases including hyperlipidemia and insulin resistance. Location Chapel Hill
Company BioLink Life Sciences Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description BioLink provides contract product development support through custom synthesis and testing for the pharmaceutical, nutraceuticals, animal health and chemical industries. Location Cary
Company Bionpharma Inc. Activity: Sales and Operations Sales and Operations Company Description Bionpharma partners with pharmaceutical companies to in-license, out-license, develop, manufacture and distribute generic and over-the-counter products. Its Raleigh location is a sales office. Location Morrisville
Company Black Swan Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. Location Wake Forest
Company Blue Ridge Institute for Medical Research Activity: Research and Development Research and Development Company Description Blue Ridge Institute for Medical Research (BRIMR) researches small-molecule inhibitors of protein kinases and targeted cancer therapies. BRIMR also generates an annual ranking of NIH funding for U.S. medical schools and their departments. Location Hendersonville
Company Bryn Pharma LLC Activity: Research and Development Research and Development Company Description Bryn Pharma is developing a nasal solution for the administration of emergency epinephrine for the treatment of anaphylaxis. Location Raleigh
Company Caeregen Therapeutics LLC Activity: Research and Development Research and Development Company Description Caeregen Therapeutics develops therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Caeregen is developing Noregen, a recombinant protein mimetic of human norrin-derived growth factor for the potential treatment of retinal-related vision loss. Location Chapel Hill
Company Campbell University Pharmaceutical Education and Research Center (PERC) Activity: Contract Research and Testing Contract Research and Testing Company Description The Pharmaceutical Education & Research Center (PERC) offers analytical, formulation, R&D, clinical manufacturing and training services to the pharma and biotech industries, compounding pharmacies, government agencies and other academic institutions. Location Buies Creek
Company Cancer Advances Inc. Activity: Research and Development Research and Development Company Description Cancer Advances, a subsidiary of Cato Bioventures, develops immunomodulator therapeutics to treat gastrointestinal cancers. Location Durham
Company Cellective BioTherapy Inc. Activity: Research and Development Research and Development Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. Location Chapel Hill
Company Cessation Therapeutics Activity: Sales and Operations Sales and Operations Company Description Cessation Therapeutics is developing novel antibody therapies to prevent and reverse overdose related to fentanyl and related synthetic opioids. The Chapel Hill site is Cessation's corporate office. Location Chapel Hill
Company Citranvi Biosciences LLC Activity: Research and Development Research and Development Company Description Citranvi develops vaccine technology platforms and products, using comprehensive structure-based vaccine design, broadly applicable to a variety of viral pathogens such as Cytomegalovirus, Epstein-Barr Virus and Coronaviruses. Location Chapel Hill
Company Clarus Biologics Inc. Activity: Research and Development Research and Development Company Description Clarus Biologics is developing innovative vaccine and immunotherapeutic products using a novel and proprietary self-amplifying mRNA delivery and viral particle technology platform. Its first innovation is a vaccine VLP that enhances the effectiveness, efficiency and availability of vaccines. Location Chapel Hill
Company Cloud Pharmaceuticals Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Cloud Pharmaceuticals designs and develops novel drug molecules using computational design for a wide range of therapeutic areas including cancer, inflammation, CNS disorders and rare diseases. Location Research Triangle Park
Company Cognosci Inc. Activity: Research and Development Research and Development Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. Location Durham
Company Collaborations Pharmaceuticals Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Collaborations Pharmaceuticals develops drugs for rare and neglected diseases using machine learning software, providing preclinical and clinical expertise to rare disease foundations, academic scientists and companies developing clinical candidates. Collaborations also provides machine learning expertise and software to consumer product and agrochemical companies. Location Raleigh
Company Couragen Biopharmaceutics LLC Activity: Research and Development Research and Development Company Description Couragen Biopharmaceutics develops gene and protein therapy products for preclinical and clinical use for the treatment of genetic and chronic diseases. Couragen also provides custom adeno-associated virus vectors as a tool for laboratory research. Location Chapel Hill
Company Creyon Bio Activity: Research and Development Research and Development Company Description Creyon Bio is a drug development company engineering RNA-based medicines and their components. Location Research Triangle Park
Company DelAQUA Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. Location Chapel Hill